US Market Overview for Soft Tissue Reinforcement and Regeneration 2017 - MedView

  • ID: 4332927
  • Report
  • Region: United States
  • 472 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • ACell
  • BioHorizons
  • Dentsply
  • KCI
  • Novus Scientific
  • Stryker
  • MORE
General Report Contents
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
If there is one factor that affects nearly every segment in this report, it’s aging population. The demographic of those over the age of 65 is increasing in the United States, which leads to a natural rise in the amount of people experiencing medical complications involving soft tissue repair. As this population grows, a greater number of devices used in surgery to augment and reinforcement suture-based repair will be purchased. Moreover, sales of products that enhance healing of chronic wounds and tendon tears are expected to increase to meet the growing demand of this population.

Soft tissue augmentation and reinforcement devices add significant costs to suture-based repair procedures. The cost varies, depending on the type of device used and the repair being performed, but in general, biological devices, such as allografts and xenografts, cost significantly more than synthetic devices within the same market segment. For instance, biological devices may offer superior long-term benefits in hernia repair by avoiding risks of infection and premature degradation and failure, but their high cost continues to deter surgeons from using them broadly, limiting the sales of the more expensive allografts and xenografts in uncomplicated hernia repair. Until biological devices can provide a justifiable benefit-cost ratio, synthetic meshes will remain dominant in the hernia repair market.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ACell
  • BioHorizons
  • Dentsply
  • KCI
  • Novus Scientific
  • Stryker
  • MORE
U.S. Soft Tissue Reinforcement And Regeneration Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.2 Disease Treatments And Diagnostics
2.2.1 Breast Cancer
2.2.2 Cardiovascular Tissue Repair
2.2.3 Dental Soft Tissue Disease
2.2.4 Diabetic Foot Ulcer
2.2.5 Dural Tears and Cerebrospinal Fluid Leakage Prevention
2.2.6 Hernia
2.2.7 Peripheral Vasculature Repair
2.2.8 Rotator Cuff and Tendon Tearing
2.2.9 Traumas and Burns
2.2.10 Urinary Incontinence
2.3 Patient Demographics
2.3.1 Breast Cancer Statistics
2.3.2 Cardiovascular Disease Statistics
2.3.3 Diabetic Foot Ulcer Statistics
2.3.4 Hernia Repair Statistics
2.3.5 Periodontitis Statistics
2.3.6 Peripheral Vascular Disease (PVD) Statistics
2.3.7 Traumatic and Sport-Related Injuries Statistics
2.3.8 Urinary Incontinence Statistics

3. U.S. Soft Tissue Reinforcement And Regeneration Market Overview
3.1 Introduction
3.2 Market Overview
3.3 Trend Analysis By Segment
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Competitive Market Share Analysis
3.6 Mergers And Acquisitions
3.7 Company Profiles
3.7.1 Acelity
3.7.2 Astora Women’s Health/AMS
3.7.3 B Braun
3.7.4 BioHorizons
3.7.5 Boston Scientific
3.7.6 Botiss Biomaterials
3.7.7 Cook Medical
3.7.8 CorMatrix
3.7.9 C.R. Bard
3.7.10 Cryolife
3.7.11 Ethicon
3.7.12 Geistlich Pharma
3.7.13 Integra LifeScience
3.7.14 Labcor
3.7.15 LeMaitre Vascular
3.7.16 LifeNetHealth
3.7.17 Medtronic
3.7.18 MiMedx
3.7.19 Organogenesis Inc.
3.7.20 RTI Surgical Inc.
3.7.21 Stryker
3.7.22 Wright Medical Group N.V.
3.8 SWOT Analysis
3.8.1 Acelity
3.8.2 Astora / AMS (closed)
3.8.3 B Braun
3.8.4 BioHorizons
3.8.5 Boston Scientific
3.8.6 Botiss Biomaterials
3.8.7 Cook Medical
3.8.8 CorMatrix
3.8.9 C.R. Bard
3.8.10 Cryolife
3.8.11 Ethicon
3.8.12 Geistlich Pharma
3.8.13 Integra LifeScience
3.8.14 Labcor
3.8.15 LeMaitre Vascular
3.8.16 LifeNet Health
3.8.17 Medtronic
3.8.18 MiMedx
3.8.19 Organogenesis Inc.
3.8.20 RTI Surgical Inc.
3.8.21 Stryker
3.8.22 Wright Medical Group N.V.

Abbreviations

Appendix: Company Press Releases

List of Charts

Chart 1 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2013 - 2023
Chart 1 2: Soft Tissue Reinforcement and Regeneration Market Overview, U.S., 2016 & 2023
Chart 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2013 - 2023
Chart 3 2: Soft Tissue Reinforcement and Regeneration Market Breakdown, U.S., 2016
Chart 3 3: Soft Tissue Reinforcement and Regeneration Market Breakdown, U.S., 2023
Chart 3 4: Growth Rates by Segment, Soft Tissue Reinforcement and Regeneration Market, U.S., 2013 - 2023
Chart 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2016

List of Figures

Figure 1 1: Soft Tissue Reinforcement and Regeneration Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Soft Tissue Reinforcement and Regeneration Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Soft Tissue Reinforcement and Regeneration Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Soft Tissue Reinforcement and Regeneration Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Soft Tissue Reinforcement and Regeneration Market, U.S., 2015 - 2017
Figure 1 7: Soft Tissue Reinforcement and Regeneration Procedures Covered, U.S., 2016
Figure 1 8: Soft Tissue Reinforcement and Regeneration Markets Covered, U.S., 2016
Figure 1 9: Key Report Updates
Figure 1 10: Version History
Figure 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2013 - 2023 (US$M)
Figure 3 2: Soft Tissue Reinforcement and Regeneration Market Growth by Segment, U.S., 2013 - 2023
Figure 3 3: Drivers and Limiters, Soft Tissue Reinforcement and Regeneration Market, U.S., 2016
Figure 3 4: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2016 (1 of 2)
Figure 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2016 (2 of 2)
Figure 3 6: SWOT Analysis, Boston Scientific, 2016
Figure 3 7: SWOT Analysis, Cook Medical, 2016
Figure 3 8: SWOT Analysis, CorMatrix, 2017
Figure 3 9: SWOT Analysis, Cryolife, 2017
Figure 3 10: SWOT Analysis, Labcor, 2017
Figure 3 11: SWOT Analysis, LeMaitre Vascular, 2017
Figure 3 12: SWOT Analysis, LifeNet health, 2017
Figure 5 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ACell
  • ASTORA
  • Aesculap/B. Braun
  • Ariste Medical
  • Arthrex
  • Atrium Medical
  • BioHorizons
  • Boston Scientific
  • C.R. Bard
  • Coloplast
  • Cook Medical
  • Covidien
  • Dentsply
  • Ethicon
  • Geistlich
  • Gore Medical
  • Integra LifeSciences
  • Johnson & Johnson
  • KCI
  • LifeCell
  • MTF
  • Medline
  • Medtronic
  • MiMedx
  • Novus Scientific
  • Organogenesis
  • Osiris
  • RTI Biologics
  • Smith & Nephew
  • Soluble Systems
  • Stryker
  • Synovis/Baxter
  • Systagenix
  • TEI
  • Tutogen
  • WL Gore
  • Wright Medical
  • Zimmer Biomet
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll